New York S 438: Prohibits the possession and transport of certain animals and body parts thereof at airports and port facilities owned or operated by the Port Authority of New York and New Jersey

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S00438 Summary:

BILL NOS00438A

&nbsp

SAME ASNo Same As

&nbsp

SPONSORMYRIE

&nbsp

COSPNSRLIU, WEBB

&nbsp

MLTSPNSR

&nbsp

Add Art 30 §§3001 - 3010, Ins L; amd §99-oo, St Fin L

&nbsp

Establishes the prescription drug supply chain transparency act; requires pharmacy services administrative organizations, pharmacy switch companies and rebate aggregators to register with the insurance department and to provide certain disclosures relating to the ownership and activities of such entities; relates to deposits into the pharmacy benefit manager regulatory fund.

Go to top S00438 Actions:

BILL NOS00438A

&nbsp

01/08/2025REFERRED TO INSURANCE

02/03/20251ST REPORT CAL.232

02/04/20252ND REPORT CAL.

02/05/2025ADVANCED TO THIRD READING 

02/25/2025PASSED SENATE

02/25/2025DELIVERED TO ASSEMBLY

02/25/2025referred to insurance

01/07/2026died in assembly

01/07/2026returned to senate

01/07/2026REFERRED TO INSURANCE

02/09/20261ST REPORT CAL.296

02/10/20262ND REPORT CAL.

02/11/2026ADVANCED TO THIRD READING 

02/24/2026PASSED SENATE

02/24/2026DELIVERED TO ASSEMBLY

02/24/2026referred to insurance

02/25/2026RECALLED FROM ASSEMBLY

02/25/2026returned to senate

02/25/2026VOTE RECONSIDERED - RESTORED TO THIRD READING

02/25/2026AMENDED ON THIRD READING 438A

03/24/2026REPASSED SENATE

03/24/2026RETURNED TO ASSEMBLY

03/24/2026referred to insurance

Go to topS00438 Committee&nbspVotes:

Go to topS00438 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS00438 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 438--A
 Cal. No. 296

 2025-2026 Regular Sessions

 IN SENATE

 (Prefiled)

 January 8, 2025
 ___________

 Introduced by Sens. MYRIE, LIU, WEBB -- read twice and ordered printed,
 and when printed to be committed to the Committee on Insurance --
 recommitted to the Committee on Insurance in accordance with Senate
 Rule 6, sec. 8 -- reported favorably from said committee, ordered to
 first and second report, ordered to a third reading, passed by Senate
 and delivered to the Assembly, recalled, vote reconsidered, restored
 to third reading, amended and ordered reprinted, retaining its place
 in the order of third reading

 AN ACT to amend the insurance law, in relation to prescription drug
 supply chain transparency; and to amend the state finance law, in
 relation to deposits into the pharmacy benefit manager regulatory fund

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. This act shall be known and may be cited as the
 2 "prescription drug supply chain transparency act".
 3 § 2. The insurance law is amended by adding a new article 30 to read
 4 as follows:
 5 ARTICLE 30
 6 PRESCRIPTION DRUG SUPPLY CHAIN TRANSPARENCY
 7 Section 3001. Definitions.
 8 3002. Electronic filing requirement.
 9 3003. Special reports and other powers.
 10 3004. Registration of pharmacy services administrative organiza-
 11 tions.
 12 3005. Required disclosures by pharmacy services administrative
 13 organizations.
 14 3006. Registration of pharmacy switch companies.
 15 3007. Required disclosures by pharmacy switch companies.
 16 3008. Registration of rebate aggregators.
 17 3009. Required disclosures by rebate aggregators.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD01699-03-6

 S. 438--A 2

 1 3010. Deposit of penalties and fees.
 2 § 3001. Definitions. (a) For the purposes of this article, the defi-
 3 nitions contained in section two hundred eighty-a of the public health
 4 law shall apply to this article as if specifically set forth herein.
 5 (b) For the purposes of this article, the following words or phrases
 6 shall have the following meanings, unless the context otherwise
 7 requires:
 8 (1) "Manufacturer" means an entity engaged in the manufacture of
 9 prescription drugs sold in this state.
 10 (2) "Pharmacy services administrative organization" or "PSAO" means an
 11 entity that is operating in this state and that contracts with a pharma-
 12 cy for the purpose of conducting business on the pharmacy's behalf with
 13 wholesalers, distributors, health plans or pharmacy benefit managers.
 14 (3) "Rebate aggregator" means an entity that pro